Repurposed drug combo tested as new hope for tough cancers
Disease control
Ongoing
This is an early-stage study testing the safety of a combination of three existing drugs—metformin, digoxin, and simvastatin—in people with advanced pancreatic cancer or other solid tumors that have worsened despite standard treatment. The main goal is to find the highest dose pa…
Phase: PHASE1 • Sponsor: Danae Hamouda, MD • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC